According to BioNTech's latest financial reports and stock price the company's current Operating Margin is -18.01%. At the end of 2022 the company had an Operating Margin of 74.83%.
Year | Operating Margin | Change |
---|---|---|
2022 | 74.83% | -5.62% |
2021 | 79.29% | -362.28% |
2020 | -30.23% | -81.7% |
2019 | -165.19% | 342.17% |
2018 | -37.36% | -73.21% |
2017 | -139.46% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.